ArticleBMC pregnancy and childbirth2026
Knowledge, attitudes, practices, and future intentions to use intermittent preventive treatment with sulfadoxine-pyrimethamine among pregnant women in southern Ghana.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionMalaria in pregnancy is a significant public health concern in sub-Saharan Africa, affecting an estimated 32 million pregnant women annually. One of WHO’s recommendations for malaria prevention is the use of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP). However, reports indicate that less than 100% of women in Ghana access IPTp service. This study explored knowledge, attitudes, uptake, and future intentions to take IPTp-SP among pregnant women in southern Ghana. METHODOLOGY: An ethnographic study design was used. Data was collected from April 20,218 to March 2019 using in-depth interviews, conversations, and non-participant observations, among pregnant women, health workers, managers, and a cross-section of community members. The interviews were recorded digitally, transcribed, and uploaded together with the transcribed conversations and observation notes into NVivo Version 11 for triangulation, coding, and thematic analysis. All ethical procedures were followed.
resultsSix major themes were identified: The context of SP administration as observed at the ANC, Post-SP advice and counseling by health providers, Knowledge of the benefits of intermittent preventive therapy in pregnancy, Frequency of SP uptake and Knowledge of recommended dosing, experience in taking in SP, and intentions of future uptake of SP. The findings show that SP uptake was well integrated into routine antenatal care and delivered through a structured, provider-led process under direct observation. Mandatory water intake and advice to eat heavy meals were common practices. Counselling on SP varied across clients and was generally limited after administration, particularly regarding side effects. Most participants received three or more SP doses in line with national guidelines and demonstrated strong trust in healthcare providers. However, knowledge of correct dosage and timing was limited, with misconceptions evident. Despite experiencing discomfort such as nausea and dizziness, most women continued SP use due to perceived maternal and fetal benefits.
conclusionStrengthening communication between healthcare providers and pregnant women regarding dosing schedules, potential side effects, and follow-up doses could improve adherence and optimize the effectiveness of malaria prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.